search
Back to results

Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. (PoPuLAR)

Primary Purpose

Uterine Myoma, Persistent Post-menpausal Bleeding, Uterine Cancer

Status
Completed
Phase
Phase 4
Locations
Sweden
Study Type
Interventional
Intervention
Normal saline
Intravenous Lidocaine
Intra-abdominal Lidocaine
Sponsored by
Örebro University, Sweden
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Uterine Myoma focused on measuring Surgery: Abdominal hysterectomy, Anesthetics: Local, Postoperative: Pain, Drugs: Morphine

Eligibility Criteria

30 Years - 75 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA 1-2
  • 30 - 75 yrs
  • Informed consent
  • 50 - 100 kg

Exclusion Criteria:

  • Allergy to LA
  • Chronic pain
  • Major liver/kidney insufficiency
  • AV Block 1-2 Participation in another clinical trial

Sites / Locations

  • Örebro University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Intravenous Lidocaine

Intra-abdominal Lidocaine

Normal saline

Arm Description

Intravenous lidocaine would be administered as an infusion for pain management both intra- and post-operatively.

Lidocaine would be administered intermittently, once each hour intra-abdominally for postoperative pain management.

Normal saline would be administered intra-abdominally and intravenously in the same patient. Rescue analgesia in the form of morphine (PCA) would be used for pain management.

Outcomes

Primary Outcome Measures

Morphine consumption
Total rescue morphine consumption during 0 - 24 h would be the primary endpoint

Secondary Outcome Measures

Postoperative pain
Postoperative pain measured on the numeric rating scale (0 - 10) would be measured at 4 h
Plasma concentration of lidocaine
The plasma concentration of LA lidocaine would be analysed at 24 h in order to assess whether the LA absorption from the abdomen is similar to that administered intravenously.
Length of Hospital stay
The time to discharge home would be assessed using standardized criteria for home discharge.

Full Information

First Posted
December 12, 2011
Last Updated
May 25, 2014
Sponsor
Örebro University, Sweden
search

1. Study Identification

Unique Protocol Identification Number
NCT01492179
Brief Title
Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.
Acronym
PoPuLAR
Official Title
A Comparison Between Continuous Infusion vs. Patient Controlled Intraabdominal Injection of Local Anesthetics for Treatment of Postoperative Pain After Abdominal Hysterectomy. A Randomized, Double-blind Study.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2014
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
June 2013 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Örebro University, Sweden

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Local anesthetics (LA) are increasingly used for postoperative pain management. Speicifically, several studies have found benefit of LA injected intra-abdominally following abdominal hysterectomy. However, it remains unclear whether the pain relief seen is due to local anesthetic mechanisms within the abdominal cavity or through systemic absorption. The aim of this study is to assess whether lidocaine administered intravenously has similar analgesic efficacy as the same dose administered intra-abdominally in patients undergoing abdominal hysterectomy. All patients would have rescue analgesia using the patient controlled analgesia (PCA) pump with morphine in order to achieve adequate pain management during 24 h.
Detailed Description
Abdominal hysterectomy with or without salipingo-oophorectomy is associated with moderate-severe postoperative pain. Poor pain control in the postoperative period can lead to increased postoperative morbidities and poor quality of life. Furthermore, an emerging clinical literature suggests that acute pain may rapidly evolve into chronic pain if poorly treated. A meta-analysis of the literature found that > 30% patients had chronic pain one year after abdominal hysterectomy (5). Therefore, efficient postoperative pain management is imperative for the patient and is one of the new pain management standards recommended recently. Local anesthetics (LA) have been infiltrated subcutaneously, infused intra-abdominally, as well as injected into the peritoneal cavity as a single dose at the end of the operation following abdominal hysterectomy with variable effects. When injected as a single dose, analgesia is limited to approximately 2-4 hours due to the short duration of action of local anesthetics. In one recent study, the authors used a catheter inserted intra-abdominally and local anesthetic or placebo infusion into the abdominal cavity for 24 h postoperatively and found a reduction in postoperative analgesic requirements by 40% during 4-24 h. In another study, the investigators found that LA injected intermittently intra-abdominally resulted in better pain relief compared to intra-abdominal infusions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Myoma, Persistent Post-menpausal Bleeding, Uterine Cancer
Keywords
Surgery: Abdominal hysterectomy, Anesthetics: Local, Postoperative: Pain, Drugs: Morphine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intravenous Lidocaine
Arm Type
Active Comparator
Arm Description
Intravenous lidocaine would be administered as an infusion for pain management both intra- and post-operatively.
Arm Title
Intra-abdominal Lidocaine
Arm Type
Active Comparator
Arm Description
Lidocaine would be administered intermittently, once each hour intra-abdominally for postoperative pain management.
Arm Title
Normal saline
Arm Type
Placebo Comparator
Arm Description
Normal saline would be administered intra-abdominally and intravenously in the same patient. Rescue analgesia in the form of morphine (PCA) would be used for pain management.
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
Normal saline would be administered intravenously and intra-abdominally.
Intervention Type
Drug
Intervention Name(s)
Intravenous Lidocaine
Other Intervention Name(s)
Xylocaine 5 mg/ml
Intervention Description
Standardized infusion of lidocaine during 24 h. 100 mg bolus and 50 mg/h during 24 h would be administered.
Intervention Type
Drug
Intervention Name(s)
Intra-abdominal Lidocaine
Other Intervention Name(s)
Xylocaine 5 mg/ml
Intervention Description
Lidocaine 5 mg/ml; 100 mg would be administered intraoperatively intra-abdominally and subsequently 50 mg/h as intermittent injection intra-abdominally during 24 h
Primary Outcome Measure Information:
Title
Morphine consumption
Description
Total rescue morphine consumption during 0 - 24 h would be the primary endpoint
Time Frame
0 - 24 h postoperatively
Secondary Outcome Measure Information:
Title
Postoperative pain
Description
Postoperative pain measured on the numeric rating scale (0 - 10) would be measured at 4 h
Time Frame
4 h postoperatively
Title
Plasma concentration of lidocaine
Description
The plasma concentration of LA lidocaine would be analysed at 24 h in order to assess whether the LA absorption from the abdomen is similar to that administered intravenously.
Time Frame
24 h
Title
Length of Hospital stay
Description
The time to discharge home would be assessed using standardized criteria for home discharge.
Time Frame
1-5 days

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA 1-2 30 - 75 yrs Informed consent 50 - 100 kg Exclusion Criteria: Allergy to LA Chronic pain Major liver/kidney insufficiency AV Block 1-2 Participation in another clinical trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kjell Axelsson, MD, PhD
Organizational Affiliation
Örebro University Hospital, Örebro, Sweden
Official's Role
Study Director
Facility Information:
Facility Name
Örebro University Hospital
City
Örebro
ZIP/Postal Code
701 85
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.

We'll reach out to this number within 24 hrs